ALFA WASSERMANN S.P.A.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,067 Total Citation Count
- Mar 27, 1984 Earliest Filing
- 45 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0065,988 PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMINApr 13, 17Mar 08, 18[C07D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0189,385 PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN AND AMINO ACIDS, PREPARATION METHODS AND USE THEREOFAbandonedAug 11, 16Jul 06, 17[A61K, C07D]
2016/0362,419 POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONSAbandonedJan 12, 16Dec 15, 16[A61K, C07D]
2016/0038,468 RIFAXIMIN FOR USE IN THE TREATING OF VAGINAL INFECTIONSAbandonedMar 03, 14Feb 11, 16[A61K]
2015/0182,508 PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMINAbandonedAug 12, 14Jul 02, 15[A61K]
2015/0175,627 POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMINAbandonedAug 12, 14Jun 25, 15[C07D]
2015/0080,421 PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASEAbandonedApr 11, 14Mar 19, 15[A61K]
2015/0072,002 USE OF POLYOLS TO OBTAIN STABLE POLYMORPHOUS FORMS OF RIFAXMINAbandonedApr 28, 14Mar 12, 15[A61K]
8640556 Automated aseptic sampling workstation and sample collection devices thereforeExpiredDec 03, 10Feb 04, 14[F16K, G01N]
2013/0183,325 MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FORMULATIONSAbandonedJan 23, 13Jul 18, 13[A61K]
2012/0258,166 RIFAXIMIN COMPOSITIONS AND METHOD OF USEAbandonedJun 19, 12Oct 11, 12[A61K, C07D, A61P]
2012/0245,192 PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASEAbandonedSep 21, 11Sep 27, 12[A61K, A61P]
2012/0238,630 COMPOSITIONS COMPRISING NONSTEROIDAL ANTI - INFLAMMATORY DRUGSAbandonedNov 17, 10Sep 20, 12[A61K, A61P]
2012/0214,989 PROCESSES FOR THE PRODUCTION OF POLYMORPHIC FORMS OF RIFAXIMINAbandonedMay 03, 12Aug 23, 12[C07D]
2012/0202,989 PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMINAbandonedApr 16, 12Aug 09, 12[C07D]
2012/0203,000 POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMINAbandonedApr 16, 12Aug 09, 12[C07D]
2012/0088,726 MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FROMULATIONSAbandonedOct 19, 11Apr 12, 12[A61K, A61P]
2012/0035,202 RIFAXIMIN COMPOSITIONS AND METHOD OF USEAbandonedOct 17, 11Feb 09, 12[A61K, C07D, A61P]
2011/0086,871 RIFAXIMIN COMPOSITIONS AND METHOD OF USEAbandonedNov 29, 10Apr 14, 11[A61K, C07D, A61P]
2010/0330,129 Gastroresistant Pharmaceutical Formulations Containing RifaximinAbandonedJan 28, 10Dec 30, 10[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
